Patents by Inventor Camille Roucairol

Camille Roucairol has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD FOR TREATING IFNALPHA RELATED CONDITIONS
    Publication number: 20180207288
    Abstract: An immunogenic product including IFN? coupled to a carrier protein molecule is capable to induce in vivo anti-IFN? antibodies and is useful in treating IFN? related conditions.
    Type: Application
    Filed: March 26, 2018
    Publication date: July 26, 2018
    Inventors: Geraldine GROUARD-VOGEL, Olivier DHELLIN, Bernard FANGET, Pierre VANDEPAPELIERE, Camille ROUCAIROL
  • Method for treating IFNalpha related conditions
    Patent number: 9993565
    Abstract: An immunogenic product including IFN? coupled to a carrier protein molecule is capable to induce in vivo anti-IFN? antibodies and is useful in treating IFN? related conditions.
    Type: Grant
    Filed: April 4, 2012
    Date of Patent: June 12, 2018
    Assignee: NEOVACS
    Inventors: Geraldine Grouard-Vogel, Olivier Dhellin, Bernard Fanget, Pierre Vandepapeliere, Camille Roucairol
  • METHOD FOR TREATING IFNALPHA RELATED CONDITIONS
    Publication number: 20140023617
    Abstract: An immunogenic product including IFN? coupled to a carrier protein molecule is capable to induce in vivo anti-IFN? antibodies and is useful in treating IFN? related conditions.
    Type: Application
    Filed: April 4, 2012
    Publication date: January 23, 2014
    Applicant: NEOVACS
    Inventors: Geraldine Grouard-Vogel, Olivier Dhellin, Bernard Fanget, Pierre Vandepapeliere, Camille Roucairol